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Abstract
Ciliary neurotrophic factor (CNTF) protects photoreceptors and regulates their phototransduction machinery, but little is
known about CNTF’s effects on retinal pigment epithelial (RPE) physiology. Therefore, we determined the expression and
localization of CNTF receptors and the physiological consequence of their activation in primary cultures of human fetal RPE
(hfRPE). Cultured hfRPE express CNTF, CT1, and OsM and their receptors, including CNTFRa, LIFRb, gp130, and OsMRb, all
localized mainly at the apical membrane. Exogenous CNTF, CT1, or OsM induces STAT3 phosphorylation, and OsM also
induces the phosphorylation of ERK1/2 (p44/42 MAP kinase). CNTF increases RPE survivability, but not rates of phagocytosis.
CNTF increases secretion of NT3 to the apical bath and decreases that of VEGF, IL8, and TGFb2. It also significantly increases
fluid absorption (JV) across intact monolayers of hfRPE by activating CFTR chloride channels at the basolateral membrane.
CNTF induces profound changes in RPE cell biology, biochemistry, and physiology, including the increase in cell survival,
polarized secretion of cytokines/neurotrophic factors, and the increase in steady-state fluid absorption mediated by JAK/
STAT3 signaling. In vivo, these changes, taken together, could serve to regulate the microenvironment around the distal
retinal/RPE/Bruch’s membrane complex and provide protection against neurodegenerative disease.
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Introduction
Ciliary neurotrophic factor (CNTF) was discovered in chicken
embryo extract where one third of its neurotrophic activity
originated in the eye [1]. It has demonstrated a remarkable
capacity for neuroprotection of rod photoreceptors in numerous
retinal degeneration models across several species [2,3,4,5,6,7].
Recently, CNTF was found to promote cone outer segment
regeneration and protect cone photoreceptors [8]. In addition,
retinal injuries induce upregulation of CNTF, which is thought to
protect photoreceptors [9,10,11]. These studies led to several
CNTF clinical trials for retinal degenerative disorders. In a phase I
clinical trial, CNTF-secreting implants (ECT) resulted in improved
visual acuity in several patients with late stages of retinitis
pigmentosa (RP) [12]. A recent clinical trial found that CNTF
implant stabilizes vision loss in patients with geographic atrophy
[13]. CNTF implants also prevent secondary cone degeneration in
patients with RP [14].
CNTF is a member of the interleukin-6 (IL6) family of
neuropoietic cytokines that includes IL11, leukemia inhibitory
factor (LIF), oncostatin M (OsM), and cardiotrophin 1 (CT1) [15].
It binds to a receptor complex of three components: CNTF
receptor a (CNTFRa) and two signal-transducing transmembrane
subunits, LIF receptor b (LIFRb) and gp130. The schematic
diagram in Figure 1 shows that LIFRb/gp130 heterodimers are
shared by CNTF, CT1, and OsM, which can also signal through
gp130/OsMRb receptor complex [16]. Previous studies suggested
the absence of LIFRb in RPE resulting in a lack of responsiveness
to CNTF (Song Y, et al. IOVS 2003;44:ARVO E-Abstract 390).
However, the development of a human culture model of RPE that
closely mimics native human adult RPE and the tight anatomical
relationship between RPE and photoreceptors prompted us to
reexamine the role of CNTF in RPE physiology. The RPE is a
monolayer of polarized epithelial cells strategically located
between the photoreceptors and the choroidal blood supply in
the posterior part of the eye. It selectively transports ions, fluid,
nutrients, and metabolic waste products between the neuronal
retina and the choriocapillaris [17] and helps maintain the health
and integrity of the distal retina by regulating the chemical
composition and volume of the extracellular spaces that face the
RPE apical and basolateral membranes [18,19,20]. Equally
important are its roles in the visual cycle [21] and in photoreceptor
outer segment renewal [22].
In the present study, we used primary cultures of hfRPE to
understand how CNTF can regulate RPE function. These cultures
molecularly and physiologically mimic native human tissue
[17,18,19,23,24,25]. We report here that the apical membrane
of hfRPE expresses all of the CNTF receptor subunits mediating
binding and signal transduction. Activation of these receptors
increases RPE survival. In addition, CNTF increases active, ion-
linked fluid absorption across the RPE while modulating the
polarized secretion of neurotrophic factors and cytokines to the
apical bath. All of these responses, taken together, likely contribute
to the protective effect of CNTF on photoreceptors [14,26,27].
PLoS ONE | www.plosone.org 1 September 2011 | Volume 6 | Issue 9 | e23148Materials and Methods
Ethics Statement
The research adhered to the tenets of the Declaration of
Helsinki and the NIH Institutional Review Board. This research
was reviewed and approved as an exemption from human subjects
(approval # 4426) by the National Institutes of Health
Institutional Review Board. Tissues were obtained with the
written informed consent of anonymised donors.
Cell cultures
Human fetal retinal pigment epithelial (hfRPE) cells were
isolated from eyes obtained from Advanced Bioscience Resources
(Alameda, CA) and cultured in PrimariaH tissue culture flasks (BD
Biosciences, Franklin Lakes, NJ) in culture medium based on
MEM-a, as described previously [23]. Culture medium was
changed every 3 days and cells were subcultured by trypsin-EDTA
treatment. Cells of passages 1 and 2 were used for all studies.
ARPE-19 (transformed cell lines from adult human RPE) was
purchased from ATCC Bioresource Center (Manassas, VA) and
grown in DMEM/F12 medium (Invitrogen, Carlsbad, CA)
containing 10% fetal bovine serum (Atlanta Biologicals, Law-
renceville, GA).
Recombinant human CNTF, CT1, and OsM, with a 66His tag
fused to the N terminus, were expressed in E.coli (XL-blue,
Stratagene, La Jolla, CA) and purified under native conditions by
immobilized-metal affinity chromatography on Ni-NTA Agarose
columns (Qiagen), as described previously [11,28,29]. Eluted
protein was buffer-exchanged to phosphate buffered saline and
stored at 280uC.
Real-time quantitative PCR
Total mRNA was extracted from confluent monolayers of
hfRPE cultured on transwells using the RNeasy Kit (Qiagen,
Valencia, CA), according to manufacturer’s instructions. Total
RNA (1 mg) was reverse transcribed to cDNA with SuperScript III
Fist-Strand Synthesis System for RT-PCR (Invitrogen). Quantita-
tive real-time PCR was performed using Taq-Man assays (Applied
Biosystems, Forster City, CA) for CNTF, CT1, OsM, CNTFRa,
LIFRb, gp130, OsMRb, and GAPDH (glyceraldehyde 3-phos-
phate dehydrogenase, whose amount was used as an internal
control) (ABI Sequence Detection System 7900; Applied Biosys-
tems). Levels of mRNA for each gene were normalized to that of
GAPDH. Data were obtained using tissues from four different
donors (three technical replicates for each gene).
Immunoblotting analyses
Confluent monolayers of primary hfRPE cells grown for 6–8
weeks in flasks were homogenized in buffer containing 250 mM
sucrose, 10 mM Tris-HCl, 10 mM MgCl2, and 1 mM CaCl2,
(pH 7.4) supplemented with proteinase inhibitor cocktail (Roche,
Indianapolis, IN). Cell lysates were centrifuged at 900 g for
10 minutes, 10,000 g for 5 minutes and 18,000 g for 20 minutes
at 4uC. Collected supernatant was centrifuged at 100,000 g for
1 hour at 4uC and plasma membrane fraction pellet was collected.
Protein was quantified by BCA protein assay (Pierce Biotechnol-
ogy, Rockford, IL).
Enriched membrane proteins (15 mg) were electrophoresed on a
NuPAGEH 3–8% Tris-Acetate Gel (Invitrogen) and electroblotted
onto nitrocellulose membranes using XCell II
TM Blot Module
(Invitrogen). Membranes were incubated in StartingBlock
TM T20
(TBS) (Pierce Biotechnology) and probed with antibodies against
CNTFRa (ab58560, Abcam, Cambridge, MA), LIFRb (AF-249-
NA, R & D Systems, Minneapolis, MN), gp130 (3732, Cell
Signaling Technology, Danvers, MA), or OsMRb (MAB4389, R
& D Systems). Human brain membrane lysate (adult, normal
tissue) was used as the positive control for CNTFRa, and whole
cell lysates of Hela and NIH3T3 cells were used as the positive
control for gp130. Membranes were then incubated with
horseradish peroxidase (HRP) conjugated secondary antibodies
(Pierce Biotechnology) and target proteins were visualized by
chemiluminescent substrate (Supersignal West Dura, Pierce
Biotechnology). Blot membranes were imaged and quantified by
measuring relative intensities using the Autochemie
TM system
(UVP, Upland, CA) using LabWorks
TM Image Acquisition and
Analysis software.
For detection of STAT3 and ERK1/2 (p44/42 MAP kinase)
phosphorylation, confluent monolayers of hfRPE or ARPE-19
cells were serum starved for 24 hour in serum free medium (SFM).
CNTF, CT1, or OsM (10–50 ng/ml) was added to the culture
medium and cells were harvested at various time points after
treatment. For blocking experiments, cells were pretreated with
JAK inhibitor I (5 mM; EMD Biosciences, Gibbstown, NJ) for
1 hour before addition of neurotrophic factors. Cells were lysed
Figure 1. Schematic diagram of CNTF, CT1 and OsM cytokine receptor complexes. The cytokines are depicted schematically as grey circles.
Signal transducing-receptor subunits are light blue (LIFRb and OsMRb) or dark blue (gp130). a-receptor subunits are shown in light grey.
doi:10.1371/journal.pone.0023148.g001
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protease inhibitor cocktail and Halt
TM phosphatase inhibitor
cocktail (Pierce Biotechnology), centrifuged at 14,000 g, and
supernatant was collected. Concentration of total protein was
determined by BCA protein assay (Pierce Biotechnology). Total
protein (40 mg) from each sample was electrophoresed on a
NuPAGEH 4–12% Bis-Tris Gel (Invitrogen) and electroblotted
onto nitrocellulose membranes. Membranes were blocked and
probed with antibodies against STAT3, phospho-STAT3
(Tyr705), ERK1/2, phospho-ERK1/2 (Thr202/Tyr204) MAP
kinase (Cell signaling Technology), and GAPDH (for loading
control, Abcam).
Immunofluorescence localization
Confluent human fetal RPE cells were maintained for 6–8
weeks in transwells (polyester membrane, 0.4 mm pore size;
Corning Costar, Corning, NY) before experiments. Cells were
fixed with 4% formaldehyde, permeabilized with 0.2% Triton X-
100 (Sigma-Aldrich), and blocked with a signal enhancer (Image-
iT FX, Invitrogen). RPE monolayers were incubated with
antibodies against CNTFRa, LIFRb, gp130, OsMRb, and ZO-
1, labeled with different fluorophores using the Zenon Labeling
Technology (Invitrogen) following manufacturer’s instructions
[30,31]. Normal mouse, rabbit, or goat serum pre-labeled with
fluorophore was used as the negative control. Samples were
mounted on glass slide with antifade reagent containing DAPI
(Prolong Gold; Invitrogen) and imaged with a Zeiss Axioplan 2
microscope with apotome and Axiovision 3.4 software (Carl Zeiss
AG, Germany).
Cell proliferation assay
Cell proliferation was measured by the BrdU (bromodeoxyur-
idin) incorporation assay [30]. Human fetal RPE cells were seeded
in 96-well PrimariaH culture plates at a density of 2.5610
3 cells/
well and allowed to attach for 24 hours, serum starved in SFM for
another 24 hours, and then replenished with SFM or SFM
containing CNTF, CT1, or OsM at various concentrations (0.6–
80 ng/ml) or medium containing 5% FBS, and incubated for
48 hours. BrdU labeling solution was then added and the cells
were incubated for another 24 hours. Cell proliferation rates were
assessed using the Cell Proliferation ELISA BrdU Kit (Roche),
according to manufacturer’s instructions. Six replicates were used
for each treatment and the experiments were repeated using cell
cultures from two donors.
Cell survivability assay
For survival assays, hfRPE cells were seeded in 24-well
PrimariaH tissue culture plate at a cell density of 2.5610
4 cells/
well and allowed to grow for 3 days. Cells were then washed and
cultured in SFM or SFM containing series concentrations of
CNTF, CT1 or OsM (0.1–100 ng/ml) for 8 days or 10 days.
Quadruplicates were used for each condition. Cell survivability
was determined by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetra-
zolium bromide (MTT) colorimetric assays, which measures the
reduction of yellow MTT by mitochondrial succinate dehydroge-
nase. Since reduction of MTT can only occur in metabolically
active cells, the level of activity is a measure of cell viability. Briefly,
MTT labeling solution (Roche) was added to the culture medium
for 4 hours, then the medium was aspirated, and solubilization
solution was added to each well. Plates were allowed to stand
overnight and each sample was measured at 580 nm (reference
wavelength: 700 nm) using a spectrophotometric microplate
reader (Safire 3; Tecan Trading AG, Mannendorf, Switzerland).
Photoreceptor outer segment (POS) preparation and
phagocytosis assay
Bovine POS were isolated under dim red light from fresh bovine
eyes obtained from a local slaughterhouse (J W Treuth & Sons Inc.,
Baltimore, MD) according to the methods of Molday et al. [32,33]
and labeled with fluorescein isothiocyanate (FITC; invitrogen).
Briefly, POS were resuspended in 1 mg/ml FITC dye in 0.1 M Na-
bicarbonate (pH 9.0) for 1 hour in the dark at room temperature.
Labeled POS were washed twice in 10% sucrose, 20 mM Na-
phosphate, pH 7.2, and twice in 2.5% sucrose in MEM and then
resuspended in 2.5% sucrose in MEM at 5610
7 POS/ml.
The phagocytosis assay was performed according to the
methods of Finnemann et al. [34,35]. Confluent monolayers of
hfRPE cultured on transwell filters were fed with FITC-conjugated
POS at a ratio of 5 OS/cell for 4 to 6 hours and rinsed four times
with PBS containing 1 mM MgCl2 and 0.2 mM CaCl2 (PBS-CM).
To quench FITC fluorescence of surface-bound but not engulfed
POS, cells were treated with 0.2% trypan blue for 10 minutes
prior to fixation. Cells were fixed by incubation in ice cold
methanol for 5 minutes followed by incubation in 4% parafor-
maldehyde in PBS-CM for 10 minutes at room temperature and
stained with Hoechst 33342. Samples with or without trypan blue
treatment were scanned using a plate reader (FITC: 495 nM/
517 nM; Hoechst 33342: 345 nm/455 nm, respectively) with a
Safire 3 spectrophotometric microplate reader; Relative fluores-
cence values were used to represent total (bound plus internal) and
internal POS, respectively. Data are presented as fluorescence
intensity ratios which were calculated by dividing FITC dye
fluorescence counts by Hoechst 33342 counts, thereby normaliz-
ing for the number of hfRPE cells.
Cytokine secretion assays
Secretion of a variety of growth factors, including b-nerve
growth factor (b-NGF), brain-derived neurotrophic factor (BDNF),
CNTF, glial cell derived neurotrophic factor (GDNF), neurotro-
phin-3 (NT3), LIF, IL6, basic fibroblast growth factor (bFGF),
vascular endothelial growth factor (VEGF), pigment epithelium-
derived factor (PEDF), IL8, monocyte chemotactic protein-1
(MCP1), insulin-like growth factor-binding protein-1 (IGFBP1)
and transforming growth factor-b2 (TGFb2) were measured in
confluent monolayers of hfRPE cultured on transwells. Cells were
washed with SFM and cultured in SFM containing 10 or 50 ng/
ml CNTF for 48 hours. Media from both the apical and basal
compartments were collected and stored at 280uC. Levels of the
factors were measured by multicomplex profiling ELISA (Search-
Light, Pierce Biotechnology) as described previously [18].
Fluid transport measurements
Confluent monolayers of hfRPE cultured on transwells were
mounted in a modified Ussing chamber and transepithelial water
flow (JV) measurements were made using a capacitance probe
technique, as described previously [18,19,36,37,38]. As illustrated
in the schematic shown in Figure 2, the hfRPE apical and
basolateral membranes are physically isolated and the chemical
composition of the solutions bathing each membrane can be
independently controlled [39,40]. In addition, tissue integrity and
transport capacity were monitored by concomitant recording of
transepithelial potential (TEP) and total tissue resistance (RT).
Steady-state JV, TEP, and RT were recorded for 20–30 minutes
after addition of CNTF to the apical or basal baths. A cAMP-
activated Cl channel inhibitor (CFTRinh-172) or a JAK inhibitor I
(EMD Biosciences) was used to block the changes of JV induced by
CNTF.
CNTF and RPE
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Values are means 6 SE. Data were analyzed using the
Student’s t-test and are considered statistically significant if
P,0.05.
Results
Expression of CNTF, CT1, OsM, LIF, and localization of
their receptors in hfRPE
We have previously shown by microarray analysis that multiple
neurotrophic factors and receptors are expressed in native human
fetal RPE cells, in primary cultures of fetal RPE, as well as in native
human adult RPE cells[24]. In hfRPE,the relative expressionlevels
of IL6 family members including CNTF, CT1, OsM, LIF and their
receptors, LIFRb, gp130, CNTFRa and OsMRb were measured
by qRT-PCR (Figure 3). Among the neurotrophic factors, LIF and
CT1 are at least 1000-fold more highly expressed than CNTF and
OsM. In addition, gp130 is the most highly expressed of the four
receptor subunits (CNTFRa, LIFRb, gp130, and OsMRb). The
presence of these four receptor subunits was further examined by
immunoblot analysis (Figure 4). CNTFRa was under the detection
limit (cells from 4 donors), but the presence of LIFRb, gp130, and
OsMRb was confirmed showing antibody-specific bands at
190 kDa, 130 kDa, and 200 kDa.
We next localized CNTFRa, LIFRb, gp130, and OsMRb
protein by immunofluorescence staining of confluent monolayers
of hfRPE primary cultures (Figure 5). Primary antibodies were
conjugated with different fluorophores to obtain image stacks
along the Z-axis. Nuclei were stained with DAPI (blue), the tight
junction marker ZO-1 in green, and the receptor subunits stained
in red. The lower portion of each panel is an enface view of the
monolayer, shown as an optical section obtained from the Z-stack.
Each panel shows a hexagonal pattern of ZO-1 staining, typical of
epithelia. CNTFRa appears as punctate staining visible through-
out the cells. The top sides of each panel show a cross-section
through the Z-plane. In these cross-sections, ZO-1 is a tight
junction marker separating the apical and basolateral sides of the
epithelial cells. Nuclei (blue) are located close to the basal side and
serve as a marker to help define basal localization. CNTFRa,
LIFRb, gp130, and OsMRb were all detected mainly on the apical
membrane of hfRPE.
Phosphorylation of STAT3 and ERK1/2
We treated hfRPE, as well as ARPE-19 cells, with CNTF, CT1,
or OsM and measured the induced phosphorylation of STAT3
and ERK1/2. In hfRPE, an increase in STAT3 phosphorylation
was detected as early as 5 minutes after treatment of CNTF, CT1,
or OsM. The induced STAT3 phosphorylation peaked at 1 hour
and lasted for 2 hours. OsM treatment also induced phosphory-
lation of ERK1/2 MAP kinase compared to the untreated control
(at 0 minute) (Figure 6A, bottom left panel), which was not seen in
cells treated with CNTF or CT1. In contrast, the CNTF-induced
phosphorylation of STAT3 was delayed in ARPE-19 compared to
hfRPE and was much weaker at all times points. CT1 treatment
had no effect on STAT3 phosphorylation in ARPE-19 cells. In
these cells, OsM treatment strongly increased the phosphorylation
of STAT3 and ERK1/2 (Figure 6A, bottom right panel).
To examine the polarity of the CNTF, CT1, or OsM induced
phosphorylation changes, we added each factor separately to the
apical or basal baths and measured the induced STAT3
phosphorylation. Addition of CNTF to the apical or basal baths
produced approximately equal STAT3 phosphorylation signals.
Addition of CT1 to the apical bath always produced a stronger
(<1.5 fold) signal than addition to the basal bath. By comparison,
Figure 2. Schematic diagram of fluid transport chamber. Top
part of figure shows internal chamber design consisting of two identical
hemichambers. Each hemichamber has a voltage-sensing electrode,
three current-passing electrodes, and a thermistor. Hemichamber A
contains media bathing the apical or retinal surface; hemichamber B
contains solution bathing the basal or choroidal surface. Surface of each
bathing solution is covered with hexadecane to eliminate evaporation.
A capacitance probe is immersed in the hexadecane in one
hemichamber. Volume change is detected by changes of distance
between probe and bathing media surface. Solutions are exchanged by
gravity flow from reservoirs through inflow valves at the bottom and
suction from the surface on top. A thin Kel-F disc (dark horizontal line) is
used to isolate probe tip from media and avoid short circuit. RPE
monolayer (E) is mounted between two circular Kel-F discs with O-rings
(shown in lower left corner of the figure). This chip is mounted between
two water-jacketed Kel-F blocks in main chamber located in a modified
CO2 incubator (5% CO2, 36.5uC) for fluid transport (Jv) measurements.
doi:10.1371/journal.pone.0023148.g002
Figure 3. Gene expression of CNTF, CT1, OsM, LIF and their
receptors in hfRPE. Relative amounts of messenger RNA were
quantified using real time PCR. All data normalized to GAPDH=10
6.
Experiments were performed in triplicate using cells from four different
donors.
doi:10.1371/journal.pone.0023148.g003
CNTF and RPE
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when added to the apical compared to the basal bath (Figure 6B).
CNTF induced STAT3 phosphorylation was completely blocked
when the cells were pretreated with JAK inhibitor I (5 mMa d d e d
to both apical and basal baths) for 1 hour, regardless of whether
CNTF was added to the apical or basal side of cells (Figure 6C),
confirming the role of JAK kinase in mediating CNTF signaling
in hfRPE cells. In another set of experiments, pretreatment with
JAK inhibitor I (5 mM added to both apical and basal baths) for
1 hour completely blocked STAT3 phosphorylation induced by
CNTF, CT1 or OsM added to both sides of the transwell
(Figure 6D).
Figure 5. Immunofluorescence localization of CNTF, CT1, OsM receptors on hfRPE. Central part of each panel is an enface view of cell
culture monolayer, shown as a single optical section obtained from a Z-stack. Nuclei were stained with DAPI (blue) and ZO-1 tight junction marker
stained green. Images of the cross section through the Z-plane are shown at the top of each panel. CNTFRa (A, red), LIFRb (B, red), gp130 (C, red) and
OsMRb (D, red) were detected mainly on the apical membrane of confluent monolayer of hfRPE.
doi:10.1371/journal.pone.0023148.g005
Figure 4. Constitutive expression of CNTF, CT1, OsM receptors in human RPE. 15 mg of enriched membrane proteins were electrophoresed
and labeled with corresponding antibodies. Antibody specific bands (see arrows) for CNTFRa, LIFRb, gp130 and OsMRb are detected at approximately
41, 190, 130, and 200 kDa, respectively. Panel A (CNTFRa) - Lane 1: Magic Mark
TM XP Western protein Standard; Lane 2: Brain (Human) membrane
lysate-adult normal tissue; Lane 3: hfRPE membrane extract. Panel B (LIFRb) - Lane 1: Magic Mark
TM XP Western protein Standard; Lane 2: hfRPE
membrane extract. Panel C (gp130) - Lane 1: HiMark
TM Molecular Weight (HMW) Standard; Lane 2: hfRPE membrane extract; Lane 3: Magic Mark
TM
XP Western protein Standard; Lane 4: Hela whole cell lysate; Lane 5: NIH3T3 whole cell lysate. Panel D (OsMRb) - Lane 1: HiMark
TM Molecular Weight
(HMW) Standard; Lane 2: hfRPE membrane extract; Lane 3: Magic Mark
TM XP Western protein Standard.
doi:10.1371/journal.pone.0023148.g004
CNTF and RPE
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We next examined the effects of CNTF, CT1, and OsM on RPE
cell proliferation and survival. The BrdU incorporation assay was
used to assess hfRPE cell proliferation. The data summarized in
Figure 7 show that CNTF had no significant effects within the tested
range (1–100 ng/ml). By comparison, CT1 significantly increased
hfRPEcell proliferation after 72 hours and the maximum stimulatory
effect was 26.669.0% at 50 ng/ml. In contrast, OsM inhibited
hfRPE proliferation monotonically from 1 to 100 ng/ml (Figure 7C).
Effects of CNTF, CT1, or OsM on cell survival were examined
by the MTT assay. At a high dose (100 ng/ml) (12.9%; P,0.05,
Figure 8A), CNTF induced an increase in hfRPE survival that is
statistically significant. No significant changes in hfRPE survival
were seen for CT1 except for a slight decrease at 10 ng/ml (27%;
P,0.05, Figure 8B). In contrast, OsM induced a significant dose-
dependent decrease in hfRPE cell survival, from 0.1 to 10 ng/ml,
with no further decrease between 10 and 100 ng/ml (Figure 8C).
RPE cell phagocytosis
It has been shown that CNTF causes a shortening of
photoreceptor outer segments [11], perhaps by activating CNTF
receptors on the RPE apical membrane and increasing phagocytic
activity. Figure 9 represent one of two independent experiments
using bovine POS with triplicate technical repeats for each group.
MFG-E8 was used as a positive control since it has been shown to
increase phagocytosis by increasing the binding rate of photore-
ceptor outer segments [41]. CNTF (50 ng/ml) had no significant
effect on phagocytosis rate compared to control and similar results
were obtained at 20 and 100 ng/ml.
CNTF alters polarized secretion of cytokines and
neurotrophic factors from hfRPE
hfRPE cells secrete a variety of growth factors, cytokines, and
neurotrophic factors. Among the factors measured, PEDF,
VEGF, MCP1, TGFb2, IL6, and IL8 are preferentially secreted
to the apical chamber at relatively high levels (0.1 to 1.0 ng)
(Figure 10A). By comparison, bFGF, CNTF, LIF, BDNF, GDNF,
and BNGF were secreted at much lower levels in a non-polarized
fashion (Figure 10A). CNTF treatment had no significant effect
on the secretion of bFGF, PEDF, IL6, MCP1, BDNF, GDNF,
BNGF and IGFBP-1 (not shown). The constitutive secretion of
NT3 is low (Figure 10A). However, its apical secretion was
Figure 6. CNTF, CT1, and OsM induced activation of STAT3 and ERK1/2 in human RPE. A. Primary cultures of hfRPE and ARPE-19 were
treated with CNTF, CT1, or OsM for a series of time points and the phosphorylation level of STAT3 and ERK1/2 were determined by Western blot
analysis. B. CNTF, CT1, and OsM were added to the apical (Ap), basolateral (Ba), or both apical and basolateral (Ap/Ba) sides of confluent monolayers
of hfRPE cells cultured on transwells for 30 minutes and phosphorylation levels of STAT3 were detected. C. Effects of JAK inhibitor I on CNTF induced
phosphorylation of STAT3. Confluent monolayers of hfRPE cells were left untreated or treated with JAK inhibitor I (5 mM; both apical and basal sides)
for 1 hour; 50 ng/ml of CNTF was added to the apical, basolateral, or both apical and basolateral side. Representative images from three separate
experiments using cells from different donors. D. Effects of JAK inhibitor I on CNTF, CT1 and OsM induced phosphorylation of STAT3. Confluent
monolayers of hfRPE cells were untreated or treated with JAK inhibitor I (5 mM; both sides) for 1 hour. 10 ng/ml of CNTF, CT1 or OsM was added to
both apical and basolateral side and the phosphorylation levels of STAT3 were detected.
doi:10.1371/journal.pone.0023148.g006
CNTF and RPE
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(Figure 10B). In striking contrast, the apical secretions of VEGF,
IL8, and TGFb2 were significantly inhibited by CNTF at 50 ng/
ml (Figure 10C–E).
CNTF increases fluid transport across RPE
Transepithelial fluid transport across confluent monolayers of
hfRPE cultures was measured in a modified Ussing chamber
(schematic in Figure 2). Figure 11A shows that addition of CNTF
(10 ng/ml) to the apical and basal baths increased fluid transport
(JV)b y8ml?cm
22?hr
21 from the retinal to the choroidal side of the
tissue. In six experiments, the mean JV increased from 14.462.1
to 23.261.8 ml?cm
22?hr
21 (n=6; P=0.01) with no significant
changes in steady-state transepithelial potential (TEP) and total
tissue resistance (RT). Adding CFTRinh-172, a specific CFTR
inhibitor (5 mM), to the basal side completely and reversibly
abolished the CNTF-induced JV increase (P=0.02), indicating
that the CNTF-induced JV increase is predominantly mediated by
CFTR chloride channels (Figure 11B). As shown in Figure 11C,
pretreatment with JAK inhibitor I (5 mM) for 30 minutes had no
effect on JV; in the presence of this inhibitor, CNTF had no effect
on JV. In three such experiments, steady-state JV was
12.862.0 ml?cm
22?hr
21 and this base line was not significantly
altered by JAK inhibitor I (14.362.9 ml?cm
22?hr
21). In the
continued presence of the JAK inhibitor I, CNTF failed to alter JV
(12.862.8 ml?cm
22?hr
21) (Figure 11D). In Figure 11E, we first
activated the JAK/STAT3 pathway with CNTF and then added
Figure 7. Dose responses of CNTF, CT1, and OsM - induced
hfRPE proliferation. CNTF showed no significant effect on hfRPE
proliferation, while CT1 significantly increased cell proliferation by 25%
(50–100 ng/ml). In contrast, OsM produced a monotonic increase in its
inhibitory effect on hfRPE proliferation between 1 and 100 ng/ml. There
was a significant difference in inhibition between 1 and 10 ng/ml
(P=0.02) and between 10 and 100 ng/ml (P=0.001). 5% FBS was used
as positive control. (Summary data from two experiments using cells
from different donors; * P,0.05, *** P,0.001 compared to 0% FBS
negative control).
doi:10.1371/journal.pone.0023148.g007 Figure 8. Dose responses of CNTF, CT1 and OsM effects on
hfRPE survivability. CNTF showed significant protection on RPE
cell survivability while OsM significantly decreased RPE cell survivability
at concentrations starting from 0.1 ng/ml. (Summary data from
experiments using cells from different donors; * P,0.05, ** P,0.01
*** P,0.001 compared to 0% FBS negative control).
doi:10.1371/journal.pone.0023148.g008
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from 9.562.5 ml?cm
22?hr
21 to 25.461.5 ml?cm
22?hr
21 (P=0.01),
and further addition of JAK inhibitor I decreased JV back to the
pretreatment baseline (10.860.9 ml?cm
22?hr
21; P=0.01;
Figure 11F). These results demonstrate that the CNTF induced
increase in JV is mediated by CFTR following activation of the
canonical JAK/STAT signaling pathway.
Discussion
We have shown that RPE cells express the neurotrophic factors,
CNTF, CT1, LIF, and OsM, and their receptors, which when
activated trigger the JAK/STAT3 signaling pathway in human
RPE. CNTF receptor activation leads to profound changes in
RPE cell physiology, via an increase in cell survival, an alteration
in the polarized secretion of neurotrophic factors and cytokines,
and an increase in fluid absorption across the RPE. Thus, the
present experiments show how CNTF and related cytokines could
influence the behavior of human RPE in vivo by leading to
chemical/volume alterations in the subretinal space (SRS) and
around Bruch’s membrane (Figure 12). These changes may
ultimately facilitate photoreceptor survival and function.
CNTF signaling and RPE survivability
In many neuronal cells, CNTF induces phosphorylation of
STAT3 as well as ERK1/2 MAP kinase [42,43,44,45]. The
presence of CNTFRa, LIFRb, gp130, and OsMRb, mainly on the
apical membrane of RPE suggest that RPE cells can respond to
changes of CNTF and related cytokines in the retina. Our results
confirmed that CNTF, CT1, and OsM all induce STAT3
phosphorylation in human RPE. The fact that we failed to detect
induction of STAT1 phosphorylation by CNTF treatment (not
shown) suggests that the JAK/STAT3 pathway is the major
signaling pathway mediating CNTF-induced changes in hfRPE. It
has been shown previously that ARPE-19 cells are not responsive
to CNTF because LIFRb is not expressed in ARPE-19 cells (Song
Y, et al. IOVS 2003;44:ARVO E-Abstract 390). However, we
observed CNTF-induced STAT3 phosphorylation in ARPE-19
cells. The induction was very weak and only detectable after
treatment for more than 30 minutes. These observations are
another reflection of the differences between transformed cell lines
(ARPE-19) and native or primary human RPE cultures [24].
Our results show that CNTF promotes human RPE cell survival
but does not induce hfRPE proliferation. In contrast, CT1 induces
hfRPE cell proliferation but does not promote survival. It is
interesting that CNTF and CT1 share the same receptor complex
of gp130 and LIFRb, but have opposite effects on hfRPE
proliferation and survival. It is quite surprising to see that OsM,
another IL-6 family member, inhibits both hfRPE proliferation
and cell survival. Human OsM, CNTF, and CT1 all bind to the
gp130/LIFRb receptors, while gp130/OsMRb is specific for OsM
[16,46,47]. Unlike CNTF and CT1, OsM not only induces
STAT3 but also ERK1/2 phosphorylation in hfRPE cells. The
possible involvement of the ERK1/2 signaling pathway may
explain the inhibitory effects of OsM on hfRPE proliferation/
survival.
CNTF alters polarized secretion of cytokines by hfRPE
Early studies suggested that CNTFRa is not expressed on
photoreceptor cells [48,49,50,51], but recent reports indicate the
expression of CNTFRa on photoreceptor precursors or even
mature photoreceptors [6,52,53,54,55,56,57]. Although the local-
ization of CNTFRa remains controversial [48,49,50,51], there is
evidence to indicate that photoreceptors are not directly
responsive to CNTF [48,49,50]. It is thought that the neuropro-
tective effects of CNTF are mediated by other retinal cells,
probably Mu ¨ller cells, that directly respond to CNTF [48,49] and
release neurotrophic factors such as bFGF [9,15]. CNTF-induced
activation of the JAK/STAT3 pathway in RPE provides another
possible mechanism for photoreceptor neuroprotection. CNTF is
found within the microglial cells of the retina (Mu ¨ller cells and
astrocytes) as well as retinal pigment epithelium [58]. CNTF
expression level increases in retinal damage [9,10,11] and part of
this increase may come from the RPE which constitutively secretes
CNTF (Figure 10A). In vivo, the subsequent activation of JAK/
STAT3 signaling could change the polarized secretion of growth
factors, cytokines, and neurotrophic factors to the SRS and thus
provide protection for rod and cone photoreceptors.
Here we show that hfRPE constitutively secretes a host of
neurotrophic factors such as CNTF, LIF, GDNF, BDNF, and
BNGF (pg/ml levels). We found that CNTF stimulates the
secretion of Neurotrophin-3 (NT3) from the apical side, but
inhibits the secretion of VEGF, IL8, and TGFb2. NT3 is a
member of the neurotrophin family, which includes NGF (nerve
growth factor), BDNF, NT3 and NT4/5 [59]. NT3 is a specific
survival factor for large proprioceptive neurons found in the dorsal
root ganglion [60] and has been shown to protect photoreceptors
Figure 9. CNTF has no significant effect on hfRPE phagocytosis.
Confluent monolayers of hfRPE received FITC-labeled POS for 4 hour
with or without CNTF (50 ng/ml) and phagocytosis rate were quantified
using relative FITC fluorescence intensity normalized to Hoechst 33342
nuclei stain. MFG-E8 (0.6 mM) was used as the positive control. Bar
graph A show relative binding+internalization and bar graph B shows
internalization only. Bars represent mean 6 SEM with triplicate
technical repeats. * P,0.05, ** P,0.01, *** P,0.001 compared to
negative control. NS: no statistical significance compared to each other.
Practically identical results were obtained in another experiment.
doi:10.1371/journal.pone.0023148.g009
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[61]. The increased release of NT3 through the RPE apical
membrane may help protect photoreceptors against retinal
degenerative disease, including AMD [62,63,64,65,66].
In contrast to the increase of NT3, secretion of VEGF, IL8, and
TGFb2 to the apical bath were substantially decreased after
CNTF treatment. VEGF is a potent permeability factor and
angiogenic growth factor whose levels increase significantly in
various ocular diseases, such as proliferative diabetic retinopathy
(PDR) and choroidal neovascularization (CNV) - the wet form of
AMD [67,68,69,70]. In CNV, the leading cause of blindness in the
elderly, it is the leakage of serum from the invading blood vessels
that causes disciform scar formation and blindness [71,72,73].
Therefore, the CNTF-induced decrease in VEGF secretion may
be protective against the serum leakage from newly formed blood
vessels that invade the SRS during CNV [72,73,74,75]. IL8 is
produced by macrophages and epithelia and its secretion is
significantly increased in inflammation [76] and angiogenesis
[74,77]. TGFb2 is critical in retinal development and involved in
programmed cell death [78,79]. TGFb signaling may be involved
in epithelial-mesenchymal-like transitions of RPE cells during
PVR [80] and is associated with inflammation and viral infection
in the retina [81]. Together, the inhibition of VEGF, IL-8, and
TGFb2 secretion by CNTF would inhibit serum leakage,
angiogenesis, and inflammation in the retina during exudative
AMD, PVR, and PDR.
CNTF increases fluid absorption across human RPE
The CNTF-induced increase in fluid absorption may be
protective in several disease states by increasing the activity of
subretinal space cytokines or neurotrophic factors. For example,
CNTF-induced decrease in SRS volume would increase the
Figure 10. Effect of CNTF on polarized cytokine secretion from hfRPE. A. Constitutive secretion of cytokine and neurotrophic factors from
confluent monolayer of hfRPE. * P,0.05, ** P,0.01, *** P,0.001 comparison between apical and basal compartment; B–C. CNTF-induced secretion
changes of NT3, IL8, VEGF, and TGFb2. * P,0.05, ** P,0.01, compared to the apical compartment of untreated control; #,0.05, compared to the
basal compartment of untreated control.
doi:10.1371/journal.pone.0023148.g010
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neuroprotective effects on nearby photoreceptors. In AMD, this
increase could help offset the CNV-induced increase in fluid
leakage from invading blood vessels [75]. The pro-inflammatory
effects of IL8 and the proliferative/migration effects of TGFb
could also be mitigated if the decrease in these secretions were
greater than the decrease in SRS volume.
Summary
In vivo, the distal retina can be protected against damage or
neurodegeneration by CNTF-induced activation of the JAK/
STAT3 signaling pathway leading to: (1) an increase in RPE
survivability; (2) increased secretion of protective factors to the
subretinal space, which possibly act in conjunction with Mu ¨ller cell
secretion; and (3) an increase in fluid absorption out of the SRS via
Figure 11. CFTRinh-172 inhibits CNTF-induced fluid transport across RPE. JV is plotted as a function of time in the top trace and net fluid
absorption (apical to basal bath) is indicated by positive values; TEP (-) and RT (D) are plotted as function of time in the lower traces. For each set of
experiments, left- hand panels (A, C, E), summary bar graphs are shown on the right-hand side (B, D, F, respectively) A. Addition of CNTF to the
apical and basal bath increased JV across monolayer of hfRPE; subsequent addition of CFTRinh-172 decreased JV back to the baseline levels (n=5). C.
Pretreatment with JAK inhibitor I (5 mM) significantly inhibited the effect of CNTF on JV increase (n=3). E. Subsequent addition of JAK inhibitor I
decreased JV induced by CNTF (n=3). * P,0.05, ** P,0.01 compared to each other.
doi:10.1371/journal.pone.0023148.g011
CNTF and RPE
PLoS ONE | www.plosone.org 10 September 2011 | Volume 6 | Issue 9 | e23148CFTR [19], which serves to maintain the normal close anatomical,
mechanical, and physiological relationship of the photoreceptor
outer segments and RPE apical membrane (Figure 12). Taken
together, all of these functions serve to maintain the health and
integrity of the neuroretina/RPE/choriocapillaris.
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